Both ANGPTL3 and apoC-III inhibit lipoprotein lipase (LPL), the enzyme responsible for hydrolyzing triglycerides in TRLs, leading to increased circulating TRLs and remnant cholesterol, which promote atherosclerosis [68]. Here, LPL is linked to atherosclerosis.